UNI-EN 102:Annual Meeting with Investors
Firma: SOPHARMA ADSpis treści:
1. REPORT
2. INFORMATION ABOUT THE ENTITY
3. SIGNATURE OF PERSONS REPRESENTING THE COMPANY
Spis załączników:
| POLISH FINANCIAL SUPERVISION AUTHORITY | |||||||||||
|
| UNI - EN REPORT No | 102 | / | 2017 | |||||||
| Date of issue: | 2017-10-05 | ||||||||||
| Short name of the issuer | |||||||||||
| SOPHARMA AD | |||||||||||
| Subject | |||||||||||
| Annual Meeting with Investors | |||||||||||
| Official market - legal basis | |||||||||||
| art. 17. 1 MAR. | |||||||||||
| Unofficial market - legal basis | |||||||||||
| Contents of the report: | |||||||||||
| NOTIFICATION We would like to notify that on November 3 2017 (Friday) Sopharma AD organizes an Annual Meeting with Investors, on which the Sopharma AD and Sopharma Trading AD will present the main goals achieved and the new challenges. The meeting will take place in the Conference center of Sopharma Business Towers, Sofia. We kindly request that all interested parties notify us not later than October 20 2017 by e-mail irevents@sopharma.bg or by telephone +3592 8134 319 in order to receive their registration forms. Places are limited. | |||||||||||
| Annexes | |||||||||||
| File | Description | ||||||||||
| 3JR_InvestorsMeeting_03112017_en.doc 3JR_InvestorsMeeting_03112017_en.doc | Annual Meeting with Investors | ||||||||||
| SOPHARMA AD | |||||||||||||
| (fullname of the issuer) | |||||||||||||
| SOPHARMA AD | Farmaceutyczny (far) | ||||||||||||
| (short name of the issuer) | (sector according to clasification of the WSE in Warsow) | ||||||||||||
| 1220 | Sofia | ||||||||||||
| (post code) | (city) | ||||||||||||
| IlienskoShosse | 16 | ||||||||||||
| (street) | (number) | ||||||||||||
| +359 2 813 42 00 | +359 2 936 02 86 | ||||||||||||
| (phone number) | (fax) | ||||||||||||
| (e-mail) | (web site) | ||||||||||||
| nd | |||||||||||||
| (NIP) | (REGON) | ||||||||||||
| SIGNATURE OF PERSONS REPRESENTING THE COMPANY | |||||
| Date | Name | Position / Function | Signature | ||
| 2017-10-05 | Ognian Donev | Executive director | |||
Cena akcji Sopharma
Cena akcji Sopharma w momencie publikacji komunikatu to 9.99 PLN. Sprawdź ile kosztuje akcja Sopharma aktualnie.
W tej sekcji znajdziesz wszystkie komunikaty ESPI EBI Sopharma.
